Translational research in autoimmunity: aims of therapy in vasculitis

Editorial

R Watts et al. Rheumatology (Oxford). 2005 May.

. 2005 May;44(5):573-6.

doi: 10.1093/rheumatology/keh609. Epub 2005 Mar 29.

No abstract available

Similar articles

Pulmonary vasculitis.
Burns A. Burns A. Br J Hosp Med. 1997 Oct 15-Nov 4;58(8):389-92. Br J Hosp Med. 1997. PMID: 9509040 Review. No abstract available.
When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
Flossmann O, de Groot K. Flossmann O, et al. Nat Clin Pract Nephrol. 2007 May;3(5):236-7. doi: 10.1038/ncpneph0468. Nat Clin Pract Nephrol. 2007. PMID: 17457358 No abstract available.
Bibliography. Current world literature. Vasculitis syndromes.
[No authors listed] [No authors listed] Curr Opin Rheumatol. 1999 Jan;11(1):B1-13. Curr Opin Rheumatol. 1999. PMID: 9894637 No abstract available.
Antineutrophil cytoplasmic antibody-associated vasculitis: autoinflammation, autodestruction and autoimmunity--key to new therapies.
Lamprecht P, Gross WL. Lamprecht P, et al. Trends Immunol. 2008 Dec;29(12):587-8. doi: 10.1016/j.it.2008.09.003. Epub 2008 Oct 24. Trends Immunol. 2008. PMID: 18951843 No abstract available.
Systemic vasculitis: still a challenging disease.
Buhaescu I, Covic A, Levy J. Buhaescu I, et al. Am J Kidney Dis. 2005 Aug;46(2):173-85. doi: 10.1053/j.ajkd.2005.04.018. Am J Kidney Dis. 2005. PMID: 16112036 Review.